Central venous catheters (CVCs) account for the largest proportion of thrombotic events in pediatric patients. Questions remain regarding adequate treatment and prevention methods” Witmer et al (2016).
Abstract:
Central venous catheters (CVCs) account for the largest proportion of thrombotic events in pediatric patients. Questions remain regarding adequate treatment and prevention methods. We surveyed pediatric hematology/oncology specialists, using hypothetical cases to assess management strategies for acute CVC thrombosis and secondary prevention.
[ctt link=”6v51V” template=”1″]ReTweet if useful… How to manage central line associated venous thrombosis in children http://ctt.ec/6v51V+ @ivteam #ivteam[/ctt]
Survey respondents varied in the use of the thrombophilia evaluation (33.3%, 41/123) and duration of treatment (6 weeks: 54.1%, 66/122). Secondary CVC prophylaxis was utilized by 36.6% (45/123) of respondents and by 24.4% (30/123) but only if there was a documented thrombophilia. This heterogeneity highlights the need for clinical studies to address these important clinical questions.
Reference:
Witmer, C.M., Sauck, E. and Raffini, L.J. (2016) A survey of pediatric hematology/oncology specialists regarding management of central line associated venous thrombosis. Paediatric Blood & Cancer. December 1st. [epub ahead of print].
DOI: 10.1002/pbc.26383
Thank you to our partners for supporting IVTEAM
[slideshow_deploy id=’23788’]